REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 152 filers reported holding REVANCE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $55,423 | -51.9% | 4,832 | +6.0% | 0.00% | -50.0% |
| Q2 2023 | $115,338 | -18.0% | 4,557 | +4.4% | 0.01% | -14.3% |
| Q1 2023 | $140,629 | +52.6% | 4,366 | -12.5% | 0.01% | +75.0% |
| Q4 2022 | $92,152 | -20.9% | 4,992 | +15.7% | 0.00% | -33.3% |
| Q3 2022 | $116,505 | +76.6% | 4,315 | -9.6% | 0.01% | +100.0% |
| Q2 2022 | $65,977 | -29.1% | 4,774 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $93,093 | -66.4% | 4,774 | -71.8% | 0.00% | -25.0% |
| Q4 2021 | $276,722 | -49.5% | 16,956 | -13.7% | 0.00% | -50.0% |
| Q3 2021 | $547,616 | -3.9% | 19,656 | +2.3% | 0.01% | 0.0% |
| Q2 2021 | $569,592 | +20.2% | 19,217 | +13.3% | 0.01% | +14.3% |
| Q1 2021 | $474,032 | -4.8% | 16,960 | -3.4% | 0.01% | 0.0% |
| Q4 2020 | $497,707 | +12.7% | 17,562 | 0.0% | 0.01% | -12.5% |
| Q3 2020 | $441,509 | +2.9% | 17,562 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $428,864 | +85.9% | 17,562 | +12.7% | 0.01% | +60.0% |
| Q1 2020 | $230,673 | -0.5% | 15,586 | +9.1% | 0.01% | +25.0% |
| Q4 2019 | $231,878 | +10.5% | 14,287 | -11.5% | 0.00% | 0.0% |
| Q3 2019 | $209,794 | +41.4% | 16,138 | +41.1% | 0.00% | +33.3% |
| Q2 2019 | $148,325 | -17.7% | 11,436 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $180,231 | -17.7% | 11,436 | +5.2% | 0.00% | -25.0% |
| Q4 2018 | $218,914 | -19.0% | 10,875 | 0.0% | 0.00% | -20.0% |
| Q3 2018 | $270,244 | -99.9% | 10,875 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $298,519,000 | +12.1% | 10,875 | +25.8% | 0.01% | +25.0% |
| Q1 2018 | $266,205,000 | +98861.0% | 8,643 | +14.7% | 0.00% | 0.0% |
| Q4 2017 | $269,000 | -37.4% | 7,537 | -51.8% | 0.00% | +33.3% |
| Q3 2017 | $430,000 | +4.4% | 15,622 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $412,000 | +48.7% | 15,622 | +17.5% | 0.00% | +50.0% |
| Q1 2017 | $277,000 | +0.7% | 13,299 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $275,000 | +27.3% | 13,299 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $216,000 | +19.3% | 13,299 | 0.0% | 0.00% | +100.0% |
| Q2 2016 | $181,000 | -22.0% | 13,299 | 0.0% | 0.00% | -50.0% |
| Q1 2016 | $232,000 | -48.9% | 13,299 | 0.0% | 0.00% | -33.3% |
| Q4 2015 | $454,000 | +37.2% | 13,299 | +19.7% | 0.00% | +50.0% |
| Q3 2015 | $331,000 | -6.8% | 11,109 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $355,000 | +153.6% | 11,109 | +53.0% | 0.00% | +100.0% |
| Q3 2014 | $140,000 | -7.3% | 7,262 | +63.6% | 0.00% | 0.0% |
| Q2 2014 | $151,000 | -45.7% | 4,439 | -49.7% | 0.00% | -50.0% |
| Q1 2014 | $278,000 | – | 8,830 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $48,000,000 | 65.50% |
| Essex Woodlands Management, Inc. | 3,842,047 | $118,335,000 | 25.90% |
| Rhenman & Partners Asset Management AB | 203,181 | $6,258,000 | 0.77% |
| EAM Global Investors LLC | 44,898 | $1,383,000 | 0.72% |
| Fosun International Ltd | 319,313 | $9,835,000 | 0.62% |
| EAM Investors, LLC | 113,096 | $3,483,000 | 0.58% |
| ArrowMark Colorado Holdings LLC | 1,735,699 | $53,460,000 | 0.53% |
| Perceptive Advisors | 618,957 | $19,064,000 | 0.53% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 111,360 | $3,430,000 | 0.45% |
| Schonfeld Strategic Advisors LLC | 83,700 | $2,578,000 | 0.19% |